Advances in the pathologic staging of lung cancer

detection of regional and systemic occult metastases.

B. Chaiwun, A. Saad, S. J. Chatterjee, C. R. Taylor, E. J. Beattie, Richard J Cote

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Approximately 78% of lung carcinomas would be potentially curable by surgery if they were detected early enough. Thus, the most important factor in predicting outcome and defining therapy is the stage of the disease. This chapter discusses the TNM (primary tumor/nodal involvement/distant metastasis) staging system for lung cancer as well as lymph node and bone marrow micrometastasis status.

Original languageEnglish
Pages (from-to)155-168
Number of pages14
JournalPathology (Philadelphia, Pa.)
Volume4
Issue number1
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Neoplasm Micrometastasis
Lung Neoplasms
Lymph Nodes
Bone Marrow
Neoplasm Metastasis
Carcinoma
Lung
Neoplasms
Therapeutics

Cite this

Advances in the pathologic staging of lung cancer : detection of regional and systemic occult metastases. / Chaiwun, B.; Saad, A.; Chatterjee, S. J.; Taylor, C. R.; Beattie, E. J.; Cote, Richard J.

In: Pathology (Philadelphia, Pa.), Vol. 4, No. 1, 01.12.1996, p. 155-168.

Research output: Contribution to journalArticle

Chaiwun, B, Saad, A, Chatterjee, SJ, Taylor, CR, Beattie, EJ & Cote, RJ 1996, 'Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases.', Pathology (Philadelphia, Pa.), vol. 4, no. 1, pp. 155-168.
Chaiwun, B. ; Saad, A. ; Chatterjee, S. J. ; Taylor, C. R. ; Beattie, E. J. ; Cote, Richard J. / Advances in the pathologic staging of lung cancer : detection of regional and systemic occult metastases. In: Pathology (Philadelphia, Pa.). 1996 ; Vol. 4, No. 1. pp. 155-168.
@article{a9e72ad4a7754d73944f9ca1bf9c077a,
title = "Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases.",
abstract = "Approximately 78{\%} of lung carcinomas would be potentially curable by surgery if they were detected early enough. Thus, the most important factor in predicting outcome and defining therapy is the stage of the disease. This chapter discusses the TNM (primary tumor/nodal involvement/distant metastasis) staging system for lung cancer as well as lymph node and bone marrow micrometastasis status.",
author = "B. Chaiwun and A. Saad and Chatterjee, {S. J.} and Taylor, {C. R.} and Beattie, {E. J.} and Cote, {Richard J}",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "4",
pages = "155--168",
journal = "Pathology (Philadelphia, Pa.)",
issn = "1041-3480",
publisher = "Hanley and Belfus Inc.",
number = "1",

}

TY - JOUR

T1 - Advances in the pathologic staging of lung cancer

T2 - detection of regional and systemic occult metastases.

AU - Chaiwun, B.

AU - Saad, A.

AU - Chatterjee, S. J.

AU - Taylor, C. R.

AU - Beattie, E. J.

AU - Cote, Richard J

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Approximately 78% of lung carcinomas would be potentially curable by surgery if they were detected early enough. Thus, the most important factor in predicting outcome and defining therapy is the stage of the disease. This chapter discusses the TNM (primary tumor/nodal involvement/distant metastasis) staging system for lung cancer as well as lymph node and bone marrow micrometastasis status.

AB - Approximately 78% of lung carcinomas would be potentially curable by surgery if they were detected early enough. Thus, the most important factor in predicting outcome and defining therapy is the stage of the disease. This chapter discusses the TNM (primary tumor/nodal involvement/distant metastasis) staging system for lung cancer as well as lymph node and bone marrow micrometastasis status.

UR - http://www.scopus.com/inward/record.url?scp=0030345673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030345673&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 155

EP - 168

JO - Pathology (Philadelphia, Pa.)

JF - Pathology (Philadelphia, Pa.)

SN - 1041-3480

IS - 1

ER -